Optiray 350 741 mg/mL (Ioversol INJECTION) 741 mg/mL

Optiray 350 741 mg/mL is a radiocontrast agent used for diagnostic imaging procedures. This injection, containing ioversol, aids in enhancing visibility during imaging studies. Learn more about its uses and effects.

Strength

741 mg/mL

Pack Size

20 SYRINGE, PLASTIC in 1 CARTON (0019-1333-78) / 50 mL in 1 SYRINGE, PLASTIC

Manufacturer / TM Owner

Liebel-Flarsheim Company LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Optiray 350 741 mg/mL is primarily used as a contrast medium for imaging studies. It helps to improve the clarity of images during procedures such as angiography and computed tomography (CT) scans. This radiocontrast agent is administered intravenously or intra-arterially to enhance the visibility of blood vessels and organs. What is Optiray 350 used for? It is commonly utilized in diagnostic imaging to provide detailed images that assist healthcare professionals in identifying abnormalities.

Side Effects

Common effects of Optiray 350 741 mg/mL may include a warm sensation or a metallic taste in the mouth. Some individuals might experience mild nausea or dizziness. These effects are generally temporary and subside quickly. It is important to note that severe reactions are rare but can occur, and immediate medical attention should be sought if any unusual symptoms arise.

Precautions & Warnings

Optiray 350 741 mg/mL should be handled with care and administered by healthcare professionals. It is essential to inform your healthcare provider about any allergies or medical conditions before use. Proper storage and handling instructions should be followed to maintain the integrity of the medication. Always use as directed by a healthcare professional.

Avoid Interactions

Optiray 350 741 mg/mL may interact with certain medications or substances. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and other substances that affect the central nervous system should be avoided. Always consult with a healthcare professional for personalized advice.

Frequently Asked Questions

Optiray 350 741 mg/mL is used as a contrast medium for diagnostic imaging procedures, enhancing visibility during angiography and CT scans.

Optiray 350 741 mg/mL is administered either intravenously or intra-arterially, depending on the specific imaging procedure.

Common effects may include a warm sensation, metallic taste, mild nausea, or dizziness, which are usually temporary.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safety.

Inform your healthcare provider about allergies or medical conditions, and follow proper storage and handling instructions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.